78 related articles for article (PubMed ID: 15112576)
21. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of peroxiredoxin in human breast cancer.
Noh DY; Ahn SJ; Lee RA; Kim SW; Park IA; Chae HZ
Anticancer Res; 2001; 21(3B):2085-90. PubMed ID: 11497302
[TBL] [Abstract][Full Text] [Related]
24. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
[TBL] [Abstract][Full Text] [Related]
25. Identification of the general transcription factor Yin Yang 1 as a novel and specific binding partner for S6 kinase 2.
Ismail HM; Myronova O; Tsuchiya Y; Niewiarowski A; Tsaneva I; Gout I
Cell Signal; 2013 May; 25(5):1054-63. PubMed ID: 23403125
[TBL] [Abstract][Full Text] [Related]
26. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids.
Shaw JL; Grass L; Sotiropoulou G; Diamandis EP
Clin Biochem; 2007 Jan; 40(1-2):104-10. PubMed ID: 17045982
[TBL] [Abstract][Full Text] [Related]
27. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues.
Sóñora C; Mazal D; Berois N; Buisine MP; Ubillos L; Varangot M; Barrios E; Carzoglio J; Aubert JP; Osinaga E
J Histochem Cytochem; 2006 Mar; 54(3):289-99. PubMed ID: 16148312
[TBL] [Abstract][Full Text] [Related]
29. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
30. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
31. High yield of biologically active recombinant human amelogenin using the baculovirus expression system.
Taylor AL; Haze-Filderman A; Blumenfeld A; Shay B; Dafni L; Rosenfeld E; Leiser Y; Fermon E; Gruenbaum-Cohen Y; Deutsch D
Protein Expr Purif; 2006 Jan; 45(1):43-53. PubMed ID: 16055347
[TBL] [Abstract][Full Text] [Related]
32. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
Liu C; Guo J; Qu L; Bing D; Meng L; Wu J; Shou C
Cancer Lett; 2008 Sep; 269(1):148-58. PubMed ID: 18586385
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of monoclonal and polyclonal antibodies against human intestinal fatty acid-binding protein (I-FABP) using synthetic regional peptides and recombinant I-FABP.
Kajiura S; Yashiki T; Funaoka H; Ohkaru Y; Nishikura K; Kanda T; Ajioka Y; Igarashi M; Hatakeyama K; Fujii H
J Immunoassay Immunochem; 2008; 29(1):19-41. PubMed ID: 18080878
[TBL] [Abstract][Full Text] [Related]
34. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
[TBL] [Abstract][Full Text] [Related]
35. [Cloning, expression, and antibody preparation of nestin with immunohistochemical analysis].
Chen XL; Liu Y; Xiao XL; Zhang J; Lü HX; Zhang PB; Liu JX; Zhao JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):196-200. PubMed ID: 16503528
[TBL] [Abstract][Full Text] [Related]
36. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
37. [Preparation of rabbit anti-STAT5 antibody and its application in breast cancer diagnosis].
Chen J; Shan BE; Chen X; Ma H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):615-7. PubMed ID: 15367362
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
40. Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway.
Martin KA; Schalm SS; Richardson C; Romanelli A; Keon KL; Blenis J
J Biol Chem; 2001 Mar; 276(11):7884-91. PubMed ID: 11108711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]